Unrecognized Tax Benefits of Monopar Therapeutics from 31 Dec 2021 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of unrecognized tax benefits.
Summary: Monopar Therapeutics quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2021 to 31 Dec 2024.
Monopar Therapeutics Unrecognized Tax Benefits for the quarter ending 31 Dec 2024 was $411,740, a 23% increase year-over-year.
Source SEC data: View on sec.gov

Unrecognized Tax Benefits, Quarterly (USD)

Unrecognized Tax Benefits, YoY Quarterly Change (%)

Monopar Therapeutics Quarterly Unrecognized Tax Benefits (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$411,740	+$75,918	+23%	31 Dec 2024	10-K	31 Mar 2025	2024	FY
Q4 2023	$335,822	+$14,647	+4.6%	31 Dec 2023	10-K	31 Mar 2025	2024	FY
Q4 2022	$321,175	+$218,071	+212%	31 Dec 2022	10-K	31 Mar 2025	2024	FY
Q4 2021	$103,104			31 Dec 2021	10-K	28 Mar 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.